Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163.
Immunol Lett. 2022 Jun 18;248:56-61. doi: 10.1016/j.imlet.2022.06.007. Online ahead of print.
Immunol Lett. 2022.
PMID: 35728747